Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

The prevalence of heart failure is on the rise and imposes a major health threat, in part, due
to the rapidly increased prevalence of overweight and obesity. To this point …

Obesity is a global issue, and it leads to various health comorbidities like cardiovascular
disease, diabetes type II and certain cancers. The relationship between obesity and cancer …

Nonalcoholic fatty liver disease (NAFLD) is a common, progressive liver disease that affects
up to one-quarter of the adult population worldwide. The clinical and economic burden of …

This work develops a thorough review of bioimpedance systems for healthcare applications.
The basis and fundamentals of bioimpedance measurements are described covering issues …

The escalating prevalence of obesity has been linked to substantial increases in both
metabolic and cardiovascular disease. Nevertheless, the direct effects of obesity on …

According to the World Health Organization, cardiovascular disease (CVD) remains the
leading cause of death worldwide, accounting for approximately 18 million deaths per year …

Obesity and diabetes are strongly associated with metabolic and cardiovascular disorders
including dyslipidemia, coronary artery disease, hypertension, and heart failure. Adipose …

Several co‐existing diseases and/or conditions (co‐morbidities) are present in patients with
heart failure (HF), with diverse clinical relevance. Multiple mechanisms may underlie the co …

There remains an unmet need to identify novel therapeutic strategies capable of protecting
the myocardium against the detrimental effects of acute ischemia–reperfusion injury (IRI), to …